Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation.
Adult
Aged
Bone Marrow Transplantation
/ statistics & numerical data
Databases, Factual
Europe
Family
Female
Graft Survival
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
/ methods
Histocompatibility
Humans
Male
Middle Aged
Peripheral Blood Stem Cell Transplantation
/ statistics & numerical data
Primary Myelofibrosis
/ mortality
Recurrence
Retrospective Studies
Societies, Medical
Survival Analysis
Transplantation Conditioning
Transplantation, Homologous
Haploidentical
Mismatched related donor
Myelofibrosis
Journal
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN: 1523-6536
Titre abrégé: Biol Blood Marrow Transplant
Pays: United States
ID NLM: 9600628
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
19
12
2017
accepted:
19
10
2018
pubmed:
9
11
2018
medline:
29
1
2020
entrez:
9
11
2018
Statut:
ppublish
Résumé
This analysis included 56 myelofibrosis (MF) patients transplanted from family mismatched donor between 2009 and 2015 enrolled in the European Society for Blood and Marrow Transplantation database. The median age was 57years (range, 38 to 72); 75% had primary MF and 25% had secondary MF. JAK2 V617F was mutated in 61%. Donors were HLA mismatched at 2 or more loci. Stem cells were sourced from bone marrow in 66% and peripheral blood in 34%. The median CD34
Identifiants
pubmed: 30408564
pii: S1083-8791(18)30650-5
doi: 10.1016/j.bbmt.2018.10.017
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
522-528Informations de copyright
Copyright © 2018 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.